Бизнес · 11.02.20021 мин чтения
Aventis Pharmaceuticals et al.; Withdrawal of Approval of 12 New Drug Applications
Локальный автоматический перевод · Язык оригинального источника
Краткое содержание
The Food and Drug Administration (FDA) is withdrawing approval of 12 new drug applications (NDAs). The holders of the applications notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.